Global Health
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Global Health (Medanta) is currently navigating a high-growth phase, underpinned by a robust expansion strategy that aims to significantly increase its hospital capacity across North and East India. Management's focus on enhancing its core network and transitioning developing hospitals towards profitability is critical for sustaining revenue growth. The company's five-year capex plan of INR 48,500 million is expected to bolster its competitive position, particularly in tertiary and quaternary care, which is experiencing structural demand. Vista's financial outlook reflects stable revenue growth and margins, supported by the operational momentum observed in recent quarters. However, execution risks related to large-scale projects and rising employee costs remain pertinent. The healthcare sector's favorable macro backdrop, characterized by stable pricing power and increasing insurance coverage, further supports Vista's positive outlook. Over the next 12-24 months, key opportunities include expanding the specialty mix and enhancing operational efficiency, while watchpoints include potential regulatory changes and competition in mature markets. Overall, the investment landscape appears cautiously optimistic, with a target price reflecting a 15% expected upside
Why We Like This Stock
- Robust expansion strategy with a significant capex plan to increase hospital capacity by approximately 95%
- Strong operational momentum driven by volume-led growth and successful execution of greenfield projects
- Stable revenue and margin outlook supported by structural demand for organized healthcare services
Things To Watch Out For
- Execution risks associated with large-scale infrastructure projects could impact profitability timelines
- Rising employee costs and competition in mature markets may pressure margins
- Potential regulatory changes affecting healthcare pricing could pose risks to revenue stability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,275 | 3,692 | 4,410 | 4,888 | 5,645 |
| Profit Before Tax (Cr.) | 626 | 697 | 714 | 770 | 930 |
| PBT Margin | 19.1% | 18.9% | 1619.0% | 15.8% | 16.5% |
| Net Profit (Cr.) | 448 | 523 | 580 | 621 | 751 |
| Earnings Per Share | 16.7 | 19.5 | 21.6 | 23.1 | 27.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Anand Rathi | ▲ Buy | 1,400 | 19-May-2026 |
| Choice Equity | ▲ Buy | 1,460 | 18-May-2026 |
| HSBC | ► Hold | 1,120 | 21-Apr-2026 |
| ICICI Securities | ▲ Buy | 1,570 | 17-May-2026 |
| Jeffries | ▲ Buy | 1,660 | 03-Aug-2026 |
| Moneycontrol | ▲ Overweight | nan | 03-Aug-2026 |
| Motilal Oswal | ▲ Buy | 1,670 | 01-Aug-2026 |
| Prabhudas Liladhar | ▲ Buy | 1,450 | 18-May-2026 |
Company Overview
Show Company Profile
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.